ACTION

Patients with colon cancer who require chemotherapy dose reductions and treatment delays are twice as likely to experience disease recurrence and death. This study will determine the optimal dose of aerobic exercise that improves chemotherapy tolerability and is feasible for colon cancer survivors.

Recruitment Sites
Baton Rouge, LA 
Boston, MA
Oakland, CA

 

Justin Brown

Principal Investigator

Jeffrey Meyerhardt

Principal Investigator

Bette Caan

Principal Investigator